Not for distribution in the U.S. or to U.S. Newswires

VANCOUVER, British Columbia, Sept. 21, 2018 (GLOBE NEWSWIRE) — BlissCo Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B), (“BlissCo”) or the (“Company”) is pleased to announce that as of today, the company’s shares of common stock were approved for trading on the OTCQB.

BlissCo is a Canadian, wellness-focused, ACMPR licensed producer and distributor of premium medical cannabis and will begin trading on the OTCQB under the ticker symbol HSTRF.

U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com .

“Qualifying for the OTCQB market demonstrates that our company’s dedication to quality and the development of a strong ecosystem of partners is paying off. This listing will provide BlissCo with greater visibility and access to different pools of capital in the U.S., ultimately reaching a broader range of investors,” said Damian Kettlewell, CEO of BlissCo Cannabis Corp. “We are on track to receive our sales license in the coming months and we anticipate having the ability to quickly begin earning revenue.”

The OTCQB market serves established U.S. and global companies that meet high financial standards while providing timely news and disclosure to investors.

About BlissCo Cannabis Corp.

BlissCo Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B) is a wellness-focused, ACMPR licensed producer and future distributor of ultra-premium cannabis. The company sits at the heart of an international ecosystem and is focused on the success of its domestic and global partnerships.

BlissCo leverages the latest technology and is continuously developing its network of top-tier industry experts to drive the success of its brand and channels, moving premium Canadian cannabis to local and international markets.

BlissCo is backed by an experienced team that is deeply in tune and integrated with industry partners and BlissCo’s future patients and customers.

Learn more: BlissCo.com

On Behalf of the Board of Directors

BLISSCO CANNABIS CORP.

Damian Kettlewell, CEO, Founder & Chair

For further information please contact:

Ariel Jack Lewinski, Business Development & Investor Relations

# 1-604-377-7533

ariel.lewinski@blissco.com

Cautionary Statement

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the ability to execute on our strategic plans and the impact on our future operations, capital expenditures, receipt of a cannabis oil license and a license to sell dried cannabis and other objectives. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.

The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.